This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Purdue Pharma L.p.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Francisco Ibanez Lopez: Innovator in Lymphoma Treatment
Introduction
Francisco Ibanez Lopez is a notable inventor based in Alicante, Spain. He has made significant contributions to the field of medical treatments, particularly in the area of lymphoma and T-cell malignant diseases. His innovative approach aims to improve patient outcomes while minimizing side effects associated with treatment.
Latest Patents
Ibanez Lopez holds a patent for "Compounds for treating lymphoma or a T-cell malignant disease." This invention relates to the use of tinostamustine in treating these conditions. The patent emphasizes an improved treatment method where the dosage of tinostamustine is adjusted based on the patient's platelet count, thereby reducing potential side effects.
Career Highlights
Throughout his career, Francisco Ibanez Lopez has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Purdue Pharma L.P. and Mundipharma International Limited. His work in these organizations has contributed to advancements in medical treatments and patient care.
Collaborations
Ibanez Lopez has collaborated with several professionals in his field, including Katarina Hilgier and Thomas Jorg Mehrling. These collaborations have fostered innovation and development in the treatment of lymphoma and related diseases.
Conclusion
Francisco Ibanez Lopez is a distinguished inventor whose work in lymphoma treatment showcases his commitment to improving patient health. His innovative patent and collaborations highlight the importance of tailored medical approaches in modern healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
